White matter hyperintensities associate with cognitive slowing in patients with systemic lupus erythematosus and neuropsychiatric symptoms

Objective To compare cognitive function between patients with different phenotypes of neuropsychiatric systemic lupus erythematosus (NPSLE) and assess its association with brain and white matter hyperintensity (WMH) volumes. Methods Patients attending the Leiden University Medical Centre NPSLE clinic between 2007 and 2015 without large brain infarcts were included (n=151; 42±13 years, 91% women). In a multidisciplinary consensus meeting, neuropsychiatric symptoms were attributed to systemic lupus erythematosus (SLE) (NPSLE, inflammatory (n=24) or ischaemic (n=12)) or to minor/non-NPSLE (n=115). Multiple regression analyses were performed to compare cognitive function between NPSLE phenotypes and to assess associations between brain and WMH volumes and cognitive function cross-sectionally. Results Global cognitive function was impaired in 5%, learning and memory (LM) in 46%, executive function and complex attention (EFCA) in 39% and psychomotor speed (PS) in 46% of all patients. Patients with inflammatory NPSLE showed the most cognitive impairment in all domains (p≤0.05). Higher WMH volume associated with lower PS in the total group (B: −0.14 (95% CI −0.32 to −0.02)); especially in inflammatory NPSLE (B: −0.36 (95% CI −0.60 to −0.12). In the total group, lower total brain volume and grey matter volume associated with lower cognitive functioning in all domains (all: 0.00/0.01 (0.00;0.01)) and lower white matter volume associated with lower LM, EFCA and PS (all: 0.00/0.01 (0.00;0.01)). Conclusion We demonstrated that an association between brain and WMH volumes and cognitive function is present in patients with SLE, but differs between (NP)SLE phenotypes. WMHs associated with PS especially in inflammatory NPSLE, which suggests a different, potentially more severe underlying pathophysiological mechanism of cognitive impairment in this phenotype.

[1]  M. van Buchem,et al.  Different phenotypes of neuropsychiatric systemic lupus erythematosus are related to a distinct pattern of structural changes on brain MRI , 2021, European Radiology.

[2]  H. Middelkoop,et al.  Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands , 2020, Lupus.

[3]  A. Mitnitski,et al.  Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment , 2020, Annals of the Rheumatic Diseases.

[4]  M. Govoni,et al.  Conventional brain magnetic resonance imaging in the longitudinal evaluation of newly diagnosed systemic lupus erythematosus patients: a retrospective analysis from a single-centre cohort , 2020, Lupus.

[5]  Frederik Barkhof,et al.  Performance of five automated white matter hyperintensity segmentation methods in a multicenter dataset , 2019, Scientific Reports.

[6]  I. Bruce,et al.  Altered cognitive function in systemic lupus erythematosus and associations with inflammation and functional and structural brain changes , 2019, Annals of the rheumatic diseases.

[7]  C. Szoeke,et al.  A decade of changes in brain volume and cognition , 2019, Brain Imaging and Behavior.

[8]  B. Volpe,et al.  Metabolic and microstructural alterations in the SLE brain correlate with cognitive impairment. , 2019, JCI insight.

[9]  S. Beyea,et al.  Nervous System Disease in Systemic Lupus Erythematosus: Current Status and Future Directions , 2018, Arthritis & rheumatology.

[10]  R. Ho,et al.  Cognitive dysfunction in patients with systemic lupus erythematosus: The challenge in diagnosis and management: , 2018 .

[11]  A. Uluğ,et al.  Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus , 2018, Lupus.

[12]  D. Centonze,et al.  Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions , 2018, Front. Aging Neurosci..

[13]  W. Kozubski,et al.  Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients , 2018, Lupus.

[14]  G. Ruiz-Irastorza,et al.  Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis , 2018, Journal of the International Neuropsychological Society.

[15]  J. Mårtensson,et al.  White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus , 2018, Lupus.

[16]  P. Sundgren,et al.  Altered white matter microstructure in lupus patients: a diffusion tensor imaging study , 2018, Arthritis Research & Therapy.

[17]  B. Shan,et al.  Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations , 2018, Front. Psychiatry.

[18]  Ruiwang Huang,et al.  Brain white matter structural networks in patients with non-neuropsychiatric systemic lupus erythematosus , 2018, Brain Imaging and Behavior.

[19]  S. Crowe,et al.  Cognitive functioning in systemic lupus erythematosus: a meta-analysis , 2018, Lupus.

[20]  O. Pasternak,et al.  The blood brain barrier and neuropsychiatric lupus: new perspectives in light of advances in understanding the neuroimmune interface. , 2017, Autoimmunity reviews.

[21]  R. Fonseca,et al.  Global Cognitive Impairment in Systemic Lupus Erythematosus Patients: A Structural MRI Study , 2017, Clinical Neuroradiology.

[22]  M. Bastin,et al.  Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus , 2016, Stroke.

[23]  L. Caniatti,et al.  Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus. , 2015, Rheumatology.

[24]  Jia Sun,et al.  Post-stroke cognitive impairment: epidemiology, mechanisms and management. , 2014, Annals of translational medicine.

[25]  P. Nederkoorn,et al.  Presence and progression of white matter hyperintensities and cognition , 2014, Neurology.

[26]  K. Awai,et al.  Brain MR Findings in Patients with Systemic Lupus Erythematosus with and without Antiphospholipid Antibody Syndrome , 2014, American Journal of Neuroradiology.

[27]  C. Filley,et al.  Cognitive Dysfunction and White Matter Abnormalities in Systemic Lupus Erythematosus , 2011, Journal of the International Neuropsychological Society.

[28]  B. Hart,et al.  Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. , 2010, Seminars in arthritis and rheumatism.

[29]  L. Pantoni Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges , 2010, The Lancet Neurology.

[30]  Li Min Li,et al.  Quantitative magnetic resonance imaging analyses and clinical significance of hyperintense white matter lesions in systemic lupus erythematosus patients , 2008, Annals of neurology.

[31]  M. Govoni,et al.  Single photon emission computed tomography and magnetic resonance imaging evaluation in SLE patients with and without neuropsychiatric involvement. , 2007, Rheumatology.

[32]  P. Emery,et al.  The validity of the inclusion of "lupus headache" in the Systemic Lupus Erythematosus Disease Activity Index. , 2007, Arthritis and rheumatism.

[33]  Li Min Li,et al.  Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus , 2007, NeuroImage.

[34]  R. Peters,et al.  Ageing and the brain , 2006, Postgraduate Medical Journal.

[35]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[36]  Li Min Li,et al.  Cerebral and corpus callosum atrophy in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[37]  P Dastidar,et al.  Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population‐based study , 2005, Scandinavian journal of rheumatology.

[38]  T. Tombaugh Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[39]  A. Auvinen,et al.  Cognitive Impairment in Systemic Lupus Erythematosus and Neuropsychiatric Systemic Lupus Erythematosus: A Population-Based Neuropsychological Study , 2003, Journal of clinical and experimental neuropsychology.

[40]  Michael Brady,et al.  Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.

[41]  D. Gladman,et al.  Systemic lupus erythematosus disease activity index 2000. , 2002, The Journal of rheumatology.

[42]  J. Ioannidis,et al.  Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus. , 2000, The American journal of medicine.

[43]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[44]  D. Symmons,et al.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. , 1996, Arthritis and rheumatism.

[45]  S. West,et al.  Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. , 1995, The American journal of medicine.

[46]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[47]  I. Bruce,et al.  Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. , 2007, Arthritis and rheumatism.

[48]  S Porter,et al.  Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. , 1998, Arthritis and rheumatism.

[49]  J. Stroop Studies of interference in serial verbal reactions. , 1992 .

[50]  D. Wechsler A Standardized Memory Scale for Clinical Use , 1945 .